Medical Device, Pharma & Investment Advisory Services
An active clinical trialist, KOL, and published investigator — available for product development, scientific advisory boards, clinical trial leadership, and investment diligence in urologic oncology.
How Dr. Tan Partners with Industry
Medical Device Companies
Focal ablation devices, biopsy platforms, robotic surgery, imaging, and hydrogel spacers. Engagements include product development input, KOL advisory boards, regulatory strategy, and clinical trial principal investigator roles.
Pharmaceutical Companies
Bladder cancer (intravesical therapies, immunotherapy) and prostate cancer (ADT, genomics, PET agents). Trial design, investigator-initiated studies, market access insight, and scientific advisory boards.
Venture Capital & Private Equity
Clinical diligence, market sizing, KOL network analysis, technology differentiation, and post-investment strategy across urologic oncology device, diagnostic, and therapeutic assets.
Areas of Deep Expertise
Selected Clinical Trial Sponsors
Dr. Tan has served as investigator or principal investigator on studies sponsored by:
Start an Engagement
Reach out for KOL work, advisory boards, clinical trial leadership, or investment diligence.